124 related articles for article (PubMed ID: 8282366)
1. Effects of a metalloendopeptidase-24.15. Inhibitor on renal hemodynamics and function in rats.
Yang XP; Saitoh S; Scicli AG; Mascha E; Orlowski M; Carretero OA
Hypertension; 1994 Jan; 23(1 Suppl):I235-9. PubMed ID: 8282366
[TBL] [Abstract][Full Text] [Related]
2. Synthetic inhibitors of endopeptidase EC 3.4.24.15: potency and stability in vitro and in vivo.
Lew RA; Tomoda F; Evans RG; Lakat L; Boublik JH; Pipolo LA; Smith AI
Br J Pharmacol; 1996 Jul; 118(5):1269-77. PubMed ID: 8818353
[TBL] [Abstract][Full Text] [Related]
3. Role of angiotensin converting enzyme in the vascular effects of an endopeptidase 24.15 inhibitor.
Telford SE; Smith AI; Lew RA; Perich RB; Madden AC; Evans RG
Br J Pharmacol; 1995 Mar; 114(6):1185-92. PubMed ID: 7620708
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of angiotensin converting enzyme by the metalloendopeptidase 3.4.24.15 inhibitor c-phenylpropyl-alanyl-alanyl-phenylalanyl-p-aminobenzoate.
Chappell MC; Welches WR; Brosnihan KB; Ferrario CM
Peptides; 1992; 13(5):943-6. PubMed ID: 1336190
[TBL] [Abstract][Full Text] [Related]
5. Evidence that enzymatic conversion of N-[1(R,S)-carboxy-3-phenylpropyl]-Ala-Ala-Phe-p-aminobenzoate, a specific inhibitor of endopeptidase 24.15, to N-[1(R,S)-carboxy-3-phenylpropyl]-Ala-Ala is necessary for inhibition of angiotensin converting enzyme.
Cardozo C; Orlowski M
Peptides; 1993; 14(6):1259-62. PubMed ID: 8134308
[TBL] [Abstract][Full Text] [Related]
6. Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.
Tomoda F; Lew RA; Smith AI; Madden AC; Evans RG
Br J Pharmacol; 1996 Sep; 119(2):365-73. PubMed ID: 8886422
[TBL] [Abstract][Full Text] [Related]
7. Potentiation by enalaprilat of fenoldopam-evoked natriuresis is due to blockade of intrarenal production of angiotensin-II in rats.
Chen C; Lokhandwala MF
Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):194-200. PubMed ID: 7477443
[TBL] [Abstract][Full Text] [Related]
8. The subtype 2 of angiotensin II receptors and pressure-natriuresis in adult rat kidneys.
Liu KL; Lo M; Grouzmann E; Mutter M; Sassard J
Br J Pharmacol; 1999 Feb; 126(3):826-32. PubMed ID: 10188997
[TBL] [Abstract][Full Text] [Related]
9. Renal actions of the selective angiotensin AT2 receptor ligands CGP 42112B and PD 123319 in the sodium-depleted rat.
Macari D; Bottari S; Whitebread S; De Gasparo M; Levens N
Eur J Pharmacol; 1993 Nov; 249(1):85-93. PubMed ID: 8282023
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive properties of inhibitors of endopeptidase 24.15.
Kest B; Orlowski M; Molineaux CJ; Bodnar RJ
Int J Neurosci; 1991; 56(1-4):141-9. PubMed ID: 1938129
[TBL] [Abstract][Full Text] [Related]
11. Effects of chymostatin, a chymase inhibitor, on blood pressure, plasma and tissue angiotensin II, renal haemodynamics and renal excretion in two models of hypertension in the rat.
Roszkowska-Chojecka MM; Walkowska A; Gawryś O; Baranowska I; Kalisz M; Litwiniuk A; Martyńska L; Kompanowska-Jezierska E
Exp Physiol; 2015 Sep; 100(9):1093-105. PubMed ID: 26011164
[TBL] [Abstract][Full Text] [Related]
12. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
Vora JP; Oyama TT; Thompson MM; Anderson S
Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
[TBL] [Abstract][Full Text] [Related]
13. Endopeptidase 24.15 modulates bradykinin-induced contraction in guinea-pig trachea.
Da Silva A; Dhuy J; Waeldelé F; Bertrand C; Landry Y
Eur J Pharmacol; 1992 Feb; 212(1):97-9. PubMed ID: 1372868
[TBL] [Abstract][Full Text] [Related]
14. Effect of inhibition of peptidase activity on distribution of intrarenal blood flow.
Bailie MD; Barbour JA
Am J Physiol; 1975 Mar; 228(3):850-3. PubMed ID: 163595
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
Seymour AA; Sheldon JH; Smith PL; Asaad M; Rogers WL
J Pharmacol Exp Ther; 1994 Apr; 269(1):263-70. PubMed ID: 8169834
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of endopeptidase 24.15 slows the in vivo degradation of luteinizing hormone-releasing hormone.
Lasdun A; Reznik S; Molineaux CJ; Orlowski M
J Pharmacol Exp Ther; 1989 Nov; 251(2):439-47. PubMed ID: 2681686
[TBL] [Abstract][Full Text] [Related]
17. Acute renal hemodynamic effects of ACE inhibition in diabetic hyperfiltration: role of kinins.
Komers R; Cooper ME
Am J Physiol; 1995 Apr; 268(4 Pt 2):F588-94. PubMed ID: 7733315
[TBL] [Abstract][Full Text] [Related]
18. Metalloendopeptidases EC 3.4.24.15 and EC 3.4.24.16 and bradykinin B2 receptors do not play important roles in renal wrap hypertension in rabbits.
Norman MU; Lew RA; Smith AI; Denton KM; Evans RG
Clin Exp Pharmacol Physiol; 2001 Oct; 28(10):836-41. PubMed ID: 11553025
[TBL] [Abstract][Full Text] [Related]
19. Intrarenal infusion of angiotensin-(1-7) modulates renal functional responses to exogenous angiotensin II in the rat.
Bürgelová M; Kramer HJ; Teplan V; Velicková G; Vítko S; Heller J; Malý J; Cervenka L
Kidney Blood Press Res; 2002; 25(4):202-10. PubMed ID: 12424421
[TBL] [Abstract][Full Text] [Related]
20. Role of kinins in the renal response to enalaprilat in normotensive and hypertensive rats.
Fitzgibbon WR; Jaffa AA; Mayfield RK; Ploth DW
Hypertension; 1996 Feb; 27(2):235-44. PubMed ID: 8567046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
